Pertussis toxin permeabilization enhances the traversal of Escherichia coli K1, macrophages, and monocytes in a cerebral endothelial barrier model in vitro.
The occasionally severe neurological complications following the human respiratory tract infection 'whooping cough' have been attributed to pertussis toxin (PT) expressed by the causative agent Bordetella pertussis. Disruption of the endothelial blood-brain barrier (BBB) by PT might facilitate the translocation of immune cells and of hematogenous microbial pathogens. To test this hypothesis, we investigated whether PT enhances the traversal of bacteria employing human brain microvascular endothelial cells (HBMEC) as an in vitro endothelial barrier model. PT incubation significantly increased the translocation of Escherichia coli K1 across the HBMEC barrier. Only intercellular E. coli K1 bacteria could be identified by electron microscopy suggesting paracellular translocation. In addition, the migration of differentiated HL60-derived macrophages and of human monocytic U937 cells through PT-treated HBMEC barriers was also enhanced. In comparison to E. coli C600, E. coli K1 showed prolonged survival in translocated HL60-derived and J774 macrophages as well as in U937 monocytes which suggested a contribution of the 'Trojan horse' mechanism. In summary, our findings demonstrate that the PT-induced permeabilization of endothelial barriers enhances the paracellular transmigration of microbes and immune cells. In vivo, this activity might lower the threshold of bacteremia facilitating secondary cerebral infections and the subsequent development of brain pathologies.
Institut für Infektiologie, Zentrum für Molekularbiologie der Entzündung, Westfälische Wilhelms-Universität/Universitätsklinikum Münster, 48149 Münster, Germany.
Gabriela
G
Seidel
Kathrin
K
Böcker
Jessica
J
Schulte
Corinna
C
Wewer
Lilo
L
Greune
Verena
V
Humberg
M Alexander
MA
Schmidt
D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000502:physiology*; D001886:Bordetella pertussis / Q000472:pathogenicity*; D002465:Cell Movement; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000187:drug effects / Q000502:physiology; D004926:Escherichia coli / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D008264:Macrophages / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D037342:Pertussis Toxin / Q000633:toxicity*
D037342:Pertussis Toxin